This expert-led session explores the latest advancements in oral delivery systems for emerging drug modalities, with a particular focus on peptides and other complex molecules. Three leading scientists are sharing innovative strategies and real-world case studies that are helping to overcome barriers in oral bioavailability. 

What you will learn:

Designing SNEDDS for Increasing Oral Absorption of Peptides
Pr. Anette Müllertz dives into lipid-based formulations, hydrophobic ion pairing (HIP), and permeation enhancers. Case studies, including exenatide and salmon calcitonin, illustrate key strategies to improve the oral absorption of peptides.

Challenges and Innovations in the Preclinical Evaluation of Targeted Oral Dosage Forms
Dr. Joseph O’Shea discusses the critical role of preclinical species (rats and pigs) in evaluating proof-of-concept formulations for targeted oral dosage forms, highlighting the advantages and limitations of different models.

Capsugel® Enprotect® Capsules: Precision Enteric Delivery Through Science and Customization
Dr. Jannin will conclude the session by focusing on the advantages of enteric capsules to protect peptides and deliver high dose in the small intestine to favor absorption.

Why Watch?

If you’re involved in drug development or oral formulation science, this session provides invaluable knowledge from leading experts in the field. Learn practical strategies to address challenges in oral bioavailability and stay at the forefront of new drug modalities.

By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest CHI content
Latest briefing from the Knowledge Center